CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

May 5, 2022 · earnings

CLDX earnings: a negative outcome, -5.6%

On May 5, 2022, Celldex Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -5.6% in the window around the event. It had already run -13.8% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$32.13
1d before
$30.34
Event day
$28.83
1d after
$28.74
5d after

Pre-catalyst setup

-13.8%
30-day run-up
5935%
30-day volatility
1.1×
volume spike